MCC-IMS are increasingly in demand for medical diagnosis, therapy and medication control via breath analyses [ 5– 7], as well as additional biological applications [ 8– 10] and process control [ 11– 13].
Attention-deficit/hyperactivity disorder participants were tested off and on medication; control subjects were never medicated but were tested twice to control for practice effects.
Some use cases are presented and evaluated using this prototype service entitled "RFID-based IoT for medication control".
This paper presents an IoT architecture, using RFID tags, able to easily and remotely establish a medication control system, beginning from physicians prescription to pharmaceutical drug administration.
Nursing observations suggested a strong connection between poorer medication control, greater risk for rejection, and signs of depression and/or anxiety.
*Blood pressure ≧ 130/85 mmHg or participants with medication control.
# Fasting glucose ≧ 100 mg/dl or participants with medication control.
In all, 34 patients with hormone-receptor-negative tumours received no further medication (control group).
About a quarter of Alzheimer patients is prescribed anti-Alzheimer medication, and in such cases patient and family caregiver visit the memory clinic regularly for medication control visits.
The lack of a "no medication" control group for the study was basically an ethical issue as it was difficult asking patients to stop medications during the study.
After a few tries, we found a medication that controlled them.
